4
Changes in Ownership
Adaptimmune Therapeutics PLC Filed Acc 0001104659-19-001304
Options or other derivatives
- Chief Operating Officer acquired 1,230,948 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Bertrand William C JR · Chief Operating Officer
Table II: Derivative
2 lines| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2019-01-04 | Grant or award : show line 1 in the form Option to purchase Ordinary Shares | +1,006,224 | 1,006,224 | D |
| 2019-01-04 | Grant or award : show line 2 in the form Option to purchase Ordinary Shares | +224,724 | 224,724 | D |
Loading xslF345X03/a4.xml…